Enalapril Maleate And Hydrochlorothiazide Tablet
Product Images NDC 51672-4045
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Enalapril Maleate And Hydrochlorothiazide (NDC 51672-4045). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Taro Pharmaceuticals U.s.a., Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Chemical Structure (Enalapril 02)
Principal Display Panel (5/12.5 mg Tablet Bottle Label)
This is a medication information for Enalapril Maleate and Hydrochlorothiazide Tablets USP. The bottle contains 100 tablets with a strength of 5mg/25mg each. The recommended dosage is indicated in the package insert or prescribing information. It should be stored at 20°C to 25°C (68°F to 77°F), protected from moisture and dispense in a tight container. The bottle also contains a desiccant. This medication is made by Taro Pharmaceuticals and the product is distributed in the USA.*
Principal Display Panel (10/25 mg Tablet Bottle Label)
This is a description of a medication called "Etibeconses". Its main ingredients are Hydrochlorothiazide and Enalapril Maleate. The tablets come in a container with a desiccant to prevent moisture. The manufacturer is Taro Pharmaceuticals, located in the USA. The medication is prescribed according to package instructions and should be stored at room temperature. The container should be kept securely closed and out of the reach of children.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.